A global healthcare company, Novo Nordisk is the leader in diabetes care. Headquartered in Denmark, Novo Nordisk has locations in 75 countries and markets in more than 180 countries.
Novo Nordisk, a world leader in medical device design and manufacturing, needed deeper understanding of the behavior of polymer materials undergoing snap-fit loads during both manufacturing and patient use of insulin-delivery pens.
SIMULIA's Polymer Customer Review team worked closely with Novo Nordisk to develop advanced software methodology based on Abaqus FEA that helps capture the complex changes that can occur in polymers and affect product integrity.
Increasingly refined analyses of material parameters enables Novo Nordisk to design more efficiently and ensure the highest levels of product performance.